These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15977623)

  • 1. [Depressive syndrome, psychoses, dementia: frequent manifestations in Parkinson disease].
    Wedekind S
    MMW Fortschr Med; 2005 Jun; 147(22):11. PubMed ID: 15977623
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 3. Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges.
    Chen JJ
    Neurol Clin; 2004 Oct; 22(3 Suppl):S63-90. PubMed ID: 15501367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease].
    Krüger R; Weiss D
    MMW Fortschr Med; 2011 Apr; 153(14):29-32; quiz 33. PubMed ID: 21966866
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychological and cognitive problems in Parkinson disease--therapeutic possibilities].
    Baronti F
    Praxis (Bern 1994); 2002 Mar; 91(10):411-7. PubMed ID: 11933648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosis in Parkinson's disease.
    Poewe W
    Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy.
    Chan-Palay V
    Adv Neurol; 1993; 60():438-46. PubMed ID: 8093581
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychological changes in Parkinson disease].
    Danielczyk W
    Wien Med Wochenschr; 1986 Aug; 136(15-16):396-9. PubMed ID: 3788191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
    Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Perioperative management of chronic treatment and medical devices. Neurological and psychiatric diseases].
    Baillard C; Blanloeil Y; Gabriel I; Melon E; Rozec B; Rigal JC;
    Ann Fr Anesth Reanim; 2011 Feb; 30(2):191-4. PubMed ID: 21316906
    [No Abstract]   [Full Text] [Related]  

  • 12. Clozapine for drug-induced psychosis in Parkinson's disease.
    Brown TM
    N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychiatric complications and shift of death age in Parkinson's disease.
    Danielczyk W; Fischer P
    Adv Neurol; 1990; 53():405-10. PubMed ID: 2239481
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of pharmacotoxic psychoses with clopenthixol in patients with Parkinson's disease (author's transl)].
    Danielczyk W
    Wien Klin Wochenschr; 1981 Aug; 93(15):500-1. PubMed ID: 7303692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iatrogenesis imperfecta.
    Friedman JH
    Med Health R I; 2002 Jul; 85(7):198. PubMed ID: 12182087
    [No Abstract]   [Full Text] [Related]  

  • 16. [The treatment of Parkinson disease].
    Jiménez-Jiménez FJ
    Med Clin (Barc); 1999 Feb; 112(7):257-8. PubMed ID: 10220753
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing psychosis in patients with Parkinson's disease.
    Cummings JL
    N Engl J Med; 1999 Mar; 340(10):801-3. PubMed ID: 10072418
    [No Abstract]   [Full Text] [Related]  

  • 18. Clozapine treatment of psychosis in patients with Parkinson's disease.
    Friedman JH
    J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160
    [No Abstract]   [Full Text] [Related]  

  • 19. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease].
    Alegre M; Noé E; Martínez Lage JM
    Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184
    [No Abstract]   [Full Text] [Related]  

  • 20. Pramipexole-induced psychosis in Parkinson's disease.
    Li CT; Tsai SJ; Hwang JP
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):245. PubMed ID: 18412854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.